My Twitter worth is: $228.80 ➡️ funxgames.me/twitterworth

Super excited to share our new paper “CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury“ just out in Annals of the Rheumatic Diseases. Great collaboration with Uta Höpken from the MDC Berlin. Janis Sonnemann Vasculitis_Lab_Berlin ard.bmj.com/content/early/…

CD36 regulates macrophage and endothelial cell activation and multinuc... sciencedirect.com/science/articl… Well done Xiang for managing to complete this work - it has not been straightforward but perseverance paid off. And in less than 10 years which is good for me !

One of the first #PEXIVAS substudies published but also one of the largest studies of lung hemorrhage in ANCA-associated vasculitis. Huge credit to Lynn Fussner for carrying this over the finish line atsjournals.org/doi/abs/10.116…

We are pleased to announce the publication of the KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis, published today in the March issue of Supplement to Kidney International, with an Executive Summary

JASN_News Benoît Brilland Maine-Anjou AAV-GN Research Group Charles Pusey Dr Dr Kate Stevens💙 Juan Manuel Mejía Imperial Medicine Thanks to #ANCA patients, brilliant collaborators, stats experts: #AKRiS predicting ESKD 👏👏👏 Duvuru Geetha Stephen McAdoo Bean Trinity Kidneys Eduardo Martín-Nares Seb Bate Dom McGovern Jennifer Scott Lauren Floyd Benoît Brilland Juan Manuel Mejía Charles Pusey Dr Dr Kate Stevens💙 + many more! 🙏🙏🙏

Looking forward to lively presentations and debates from our international faculty panel - Shikha Wadhwani AMAN SHARMA 🇮🇳 Duvuru Geetha Suceena Alexander purva sharma & Carla Nester Registration is free & open to all!

1/🚨#Tweetorial🚨 To all #ANCAvasculitis #AAV enthusiasts, have you ever wondered if avacopan has lived up to the hype since the publication of #ADVOCATE? Today, I will share the results of the "Avacopan: real-world experience" project led by Duvuru Geetha at Hopkins Nephrology

Design of a recovery prediction tool for ANCA vasculitis presented by the brilliant Silke R Brix at #vasculitisBCN2024

Emotional handing of the baton to ANZ Vasculitis Society Richard Kitching, Catherine Hill and Vicky Quincy. The next #vasculitis workshop will be in Melbourne, Australia! Feb 2026.

Thank you Maria and team for an amazing #vasculitis2024 meeting. See you all in Melbourne.

Philipp Enghard Brilliant Good to hear journals.lww.com/jasn/fulltext/…

New review by purva sharma on ANCA vasculitis akdh.org/article/S2949-… AKDH National Kidney Foundation

Really enjoyed the discussions of experts in the glomerular diseases GlomCon

Poyan Mehr Joana Gameiro Marco Bonilla Sayna Norouzi, MD, FASN Sol Carriazo, Neph. Zainab Obaidi Mohamed H. Hassanein | محمد حسنين Paul E. Hanna, MD MSc Stephanie Torres M.D. Alejandro Garcia-Rivera Harish Seethapathy From the first GlomCon session from my apt in SF in 2017 to #GlomConHawaii in 2024… you had a vision & you made it happen & you changed the world of GN forever Poyan Mehr! I hope you were able to reflect on that for at least a moment in the magical setting of Hawaii!

22nd International Vasculitis Workshop, Melbourne 2026 The biggest and definitive biannual meeting of the #Vasculitis Research, Clinical and Patient Community Go to vasculitis-melbourne2026.com to register your interest. More to follow. See you in Melbourne in the southern summer!

NEW RESEARCH—Model-based clustering of a federated international cohort produces a data-driven subclassification of ANCA-associated #vasculitis that exhibits higher predictive value than current approaches for key outcomes thelancet.com/journals/lanrh… FAIRVASC Vasculitis_Lund

🌟Join our Glomerular Diseases Fellowship Hopkins Nephrology for July 2024 - June 2025!🌟 🔬 Dive into rare diseases, research & patient care 📚 Comprehensive training in nephrology 🌎 ACGME residency and nephrology fellowship required 🌐 J1/H1B visas welcome 📄 Application details 👇

📄 hopkinsmedicine.org/nephrology/edu… 📧 Send CV, 3 recs, & personal statement to [email protected]. 🔍 Queries? Contact Dr. John Sperati ([email protected]) or Dr. Duvuru Geetha ([email protected]). #NephrologyFellowship #GlomerularDiseases #MedEd

Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism–related vascular thrombosis with microvascular injury and its consequences doi: 10.1016/j.kint.2024.07.020 Universität München DZHK Germany Uniklinik RWTH AC Hans-Joachim Anders Ohio State Nephrology #AKI #diabetes